Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
(WorldNews Europe)

Genmab A/S Inside information Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen Company Announcement Genmab to receive milestone payment of USD 100 Million in DARZALEX collaboration Milestone triggered by sales of DARZALEX reaching USD 2.5 billion in a calendar year Copenhagen, Denmark; December 5, 2019 - Genmab A/S (Nasdaq: GMAB) announced today that it has achieved a USD 100 million sales volume milestone in its DARZALEX® (daratumumab) collaboration with Janssen Biotech, Inc. The milestone was triggered by confirmation from Janssen that sales of DARZALEX reached USD 2.5 billion in a calendar year. In August 2012, Genmab granted Janssen an...